Biotech2050 Podcast: Cellarity CEO Fabrice Chouraqui on how AI/ML are Revolutionizing Drug Discovery

08.28.24

Media

Section Heading	Section Content
Biotech2050 Podcast:	August 28, 2024 \| Cellarity CEO Fabrice Chouraqui sits down with Rahul Chaturvedi, host of the Biotech2050 Podcast, to discuss his transition from pharma to biotech, how artificial intelligence and machine learning are revolutionizing drug discovery, and the Cellarity approach to bringing innovative medicines to patients faster. Listen to the podcast here.

Section Heading

Section Content

Biotech2050 Podcast:

August 28, 2024 | Cellarity CEO Fabrice Chouraqui sits down with Rahul Chaturvedi, host of the Biotech2050 Podcast, to discuss his transition from pharma to biotech, how artificial intelligence and machine learning are revolutionizing drug discovery, and the Cellarity approach to bringing innovative medicines to patients faster.

Listen to the podcast here.

Biotech2050 Podcast · Advancing Drug Discovery with Cutting-Edge AI & Team Synergy: Fabrice Chouraqui, CEO of Cellarity

Up Next

View All

Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes. Science, 2025

No results found.

CLY-124 Sickle Cell

Biotech2050 Podcast: Cellarity CEO Fabrice Chouraqui on how AI/ML are Revolutionizing Drug Discovery

Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes. Science, 2025

Platform

CLY-124 Sickle Cell

Pipeline

About Us

Life at Cellarity

News & Events

Science with us – keep up to date with Cellarity